 Q BioMed Inc. has recently entered into an exclusive distribution agreement with isoSolutions Marketing Management Inc., a well-known distributor in Canada providing services and solutions to the nuclear medicine, radioisotope research, pharmaceutical, and medical device industries. Under the terms of the agreement, Q BioMed said isoSolutions has received the exclusive rights to distribute Strontium89 in Canada. 